AmBase Corp
ABCP is a shell corporation with zero revenue, massive operating losses, and a negative net worth trading on the OTC markets.
ABCP is a shell corporation with zero revenue, massive operating losses, and a negative net worth trading on the OTC markets.
A speculative investor might purchase ABCP as a high-risk turnaround play, betting that the company will successfully restructure its debt or find a strategic acquirer to absorb the shell entity. The current negative equity position could be viewed as a 'distressed opportunity' if management can execute a successful capital raise or asset acquisition to reverse the deficit.
ABCP should be avoided by all investors due to its fundamental lack of business, zero revenue stream, and deteriorating financial health evidenced by three consecutive years of increasing losses. The company is effectively insolvent with liabilities exceeding assets, making it a candidate for liquidation rather than sustainable growth.
AmBase Corp (ABCP) operates as a shell entity with minimal operational assets, reporting zero revenue and significant accumulated deficits across its OTC markets. The company maintains negligible cash reserves relative to its total liabilities while engaging in substantial equity issuances to fund operations or restructuring efforts. Financial records indicate no gross profit generation, suggesting the business model relies entirely on capital structure changes rather than traditional product sales.
Recent financial performance shows a widening loss trend, with net income deteriorating from -$3.5M in 2022 to -$6.6M in 2024, indicating accelerating operational inefficiencies or costs without corresponding revenue growth. The cash flow from financing of $9.1M is entirely dependent on equity issuance rather than organic business performance, while operating expenses of $6.5M far exceed any potential earnings power.
The OTC market segment includes numerous shell companies and distressed entities that lack traditional operational metrics and often rely on capital raising to survive. Companies in this space typically operate without established products or services, facing intense scrutiny regarding their ability to generate future cash flow from operations.
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| Operating Expenses | $3.4M | $5.0M | $6.5M |
| Operating Income | $-3.4M | $-5.0M | $-6.5M |
| Non-Operating Income | $-48.0K | $-239.0K | $-102.0K |
| Interest Expense | $57.0K | $241.0K | — |
| Interest Income | $9.0K | $2.0K | $29.0K |
| Pre-Tax Income | $-3.5M | $-5.3M | $-6.6M |
| Income Tax | $1.0K | $1.0K | $1.0K |
| Continuing Ops | $-3.5M | $-5.3M | $-6.6M |
| Discontinued Ops | $0 | $0 | $0 |
| Net Income | $-3.5M | $-5.3M | $-6.6M |
| Minority Interest | $0 | $0 | $0 |
| Net to Common | $-3.5M | $-5.3M | $-6.6M |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $349.0K | $78.0K | $314.0K |
| Total Assets | $410.0K | $78.0K | $314.0K |
| Total Liabilities | $1.5M | $6.4M | $4.4M |
| Shareholders' Equity | $-1.1M | $-6.3M | $-4.1M |
| Retained Earnings | $-544.7M | $-549.9M | $-556.6M |
| Total L&E | $410.0K | $78.0K | $314.0K |
| Metric | 2022 | 2023 | 2024 |
|---|---|---|---|
| Net Income (CFO) | $-3.5M | $-5.3M | $-6.6M |
| Non-Cash Adjustments | $38.0K | $122.0K | $0 |
| Working Capital Changes | $781.0K | $1.7M | $-2.3M |
| Cash from Operations | $-2.7M | $-3.5M | $-8.9M |
| Cash from Investing | — | $0 | $0 |
| Cash from Financing | — | $3.2M | $9.1M |
| FX Effect | $0 | $0 | $0 |
| Net Change in Cash | $-2.7M | $-271.0K | $236.0K |
| Beginning Cash | $3.0M | $349.0K | $78.0K |
| Ending Cash | $349.0K | $78.0K | $314.0K |
The company currently has no active revenue-generating segments; all reported financial activity stems from financing operations such as common share issuances ($8.8M) and interest income on minimal cash balances. The primary 'segment' is the capital structure itself, characterized by a retained earnings deficit of $556.6M and total liabilities exceeding total assets.
The company faces extreme insolvency risk with negative shareholders' equity of $4.1M against total liabilities of $4.4M. Investors must consider the high dilution risk from frequent common share issuances used to cover operating losses. There is no revenue generation, creating a fundamental liquidity crisis where cash flow from operations remains deeply negative at $8.9M annually.
None identified based on current financials; the company lacks traditional competitive moats such as proprietary technology, market share, or cost advantages due to zero revenue operations.
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.